International Journal of Pharmaceutical Compounding

A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

LEARN MORE

Spironolactone 5 mg/mL in SuspendIt Oral Suspension

Author(s): Allen Loyd V Jr

Issue: Nov/Dec 2017 - Volume 21, Number 6
View All Articles in Issue

Page(s): 496

Spironolactone 5 mg/mL in SuspendIt Oral Suspension Page 1

Download in electronic PDF format for $75

Abstract: A formulation for preparing Spironolactone 5 mg/mL in SuspendIt Oral Suspension. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords: Loyd V. Allen, Jr., PhD, RPh, formulation, spironolactone, potassium-sparing diuretic, aldosterone antagonist, high blood pressure, hypertension, antihypertensive agent, congestive heart failure, fluid overload, fluid retention, edema, ascites, liver failure, hepatic disease

Related Categories: FORMULATIONS, GASTROENTEROLOGY, CARDIOLOGY, UROLOGY/URINARY TRACT

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
Spironolactone 5 mg/mL in SuspendIt Oral Suspension Allen Loyd V Jr	Nov/Dec 2017 Pg. 496
Spironolactone 5-mg/mL in Suspendit Oral Suspension Allen Loyd V Jr	Mar/Apr 2018 Pg. 152
Stability of Spironolactone Oral Suspension in PCCA Base, SuspendIt Graves Richard, Phan Kelly V, Bostanian Levon A, Mandal Tarun K, Pramar Yashoda V	Jul/Aug 2017 Pg. 334-338
Spironolactone 2-mg/mL or 2-5.mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Sep/Oct 2021 Pg. 421
Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh Allen Loyd V Jr	Nov/Dec 2003 Pg. 449-450
Compounding in the Pharmacy Curriculum: Beyond the Basics Hinkle Amanda R, Newton Gail D	May/Jun 2004 Pg. 181-185
Torsemide 5 mg/mL in Ora-Plus:Ora-Sweet Suspension Allen Loyd V Jr	Sep/Oct 2018 Pg. 411
Basics of Compounding for Cough Allen Loyd V Jr	Nov/Dec 2004 Pg. 462-465
Congestive Heart Failure and Other Medical Facts About Ferrets; Scout's Story: A Case Report on Treating Congestive Heart Failure in a Ferret Williams LaVonn A, Riley Kari	Sep/Oct 2009 Pg. 367-371
Amlodipine Besylate 0.5-mg/mL to 10-mg/mL in SuspendIt Oral Suspension Allen Loyd V Jr	Jan/Feb 2021 Pg. 43
Carvedilol 1.25-mg/mL Oral Suspension Allen Loyd V Jr	May/Jun 2006 Pg. 220
Metoprolol Tartrate 10 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Nov/Dec 2021 Pg. 503
Losartan Potassium 2.5-mg/mL Oral Liquid Allen Loyd V Jr	Jul/Aug 2023 Pg. 326
Captopril 0.8 mg/mL in SyrSpend SF Oral Suspension Allen Loyd V Jr	Mar/Apr 2019 Pg. 148
Valsartan 4 mg/mL in Vehicle for Oral Solution USP Allen Loyd V Jr	Sep/Oct 2019 Pg. 412
Losartan Potassium 2.5-mg/mL Oral Liquid Allen Loyd V Jr	May/Jun 2007 Pg. 248
Wetting and/or Solubilizing Agents, Featured Excipient: Allen Loyd V Jr	Jul/Aug 2001 Pg. 310-312
Candesartan Cilexetil 0.1-mg/mL to 2.0-mg/mL Oral Suspension Allen Loyd V Jr	May/Jun 2017 Pg. 232
Bumetanide 0.25-mg/mL Injection Allen Loyd V Jr	Jan/Feb 2014 Pg. 61
Compatibility of Baclofen, Carvedilol, Hydrochlorothiazide, Mercaptopurine, Methadone Hydrochloride, Oseltamivir Phosphate, Phenobarbital, Propranolol Hydrochloride, Pyrazinamide, Sotalol Hydrochloride, Spironolactone, Tacrolimus Monohydrate, Ursodeoxycholic Acid, and Vancomycin Hydrochloride Oral Suspensions Compounded with SyrSpend SF pH4 Polonini Hudson, da Silva Sharlene Loures, Brandão Marcos Antônio Fernandes, Bauters Tiene, De Moerloose Barbara, Ferreira Anderson de Oliveira	Nov/Dec 2018 Pg. 516-526
Return to Top